Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy

[1]  Yingyuan Zhao,et al.  A Dual-Mechanism Based Nutrient Partitioning Nanoregulator for Enhanced Immunotherapy against Anti-PD-1 Resistant Tumors. , 2023, ACS nano.

[2]  Pankaj Singh,et al.  Nucleotide metabolism: a pan-cancer metabolic dependency , 2023, Nature Reviews Cancer.

[3]  Zhaohui Wang,et al.  Harnessing Nanomaterials for Cancer Sonodynamic Immunotherapy , 2023, Advanced materials.

[4]  I. Ben-Sahra,et al.  Regulation of nucleotide metabolism in cancers and immune disorders. , 2023, Trends in cell biology.

[5]  J. Rathmell,et al.  Metabolic programming and immune suppression in the tumor microenvironment. , 2023, Cancer cell.

[6]  Peng Liu,et al.  Reversing the negative effect of adenosine A1 receptor-targeted immunometabolism modulation on melanoma by a co-delivery nanomedicine for self-activation of anti-PD-L1 DNAzyme , 2023, Nano Today.

[7]  Hongyoon Choi,et al.  Mannosylated-serum albumin nanoparticle imaging to monitor tumor-associated macrophages under anti-PD1 treatment , 2023, Journal of Nanobiotechnology.

[8]  Jinti Lin,et al.  Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells , 2023, Frontiers in Oncology.

[9]  Ligeng Xu,et al.  Metabolic Reprogramming of NK Cells by Black Phosphorus Quantum Dots Potentiates Cancer Immunotherapy , 2023, Advanced science.

[10]  Yuanyuan Yang,et al.  Carrier-Free Immunotherapeutic Nano-Booster with Dual Synergistic Effects Based on Glutaminase Inhibition Combined with Photodynamic Therapy. , 2023, ACS nano.

[11]  Zhen-kui Sun,et al.  HIF-1α/YAP Signaling Rewrites Glucose/Iodine Metabolism Program to Promote Papillary Thyroid Cancer Progression , 2023, International journal of biological sciences.

[12]  Yan Yang,et al.  Dynamic tagging to drive arginine nano-assembly to metabolically potentiate immune checkpoint blockade therapy. , 2023, Biomaterials.

[13]  Yongzhuo Huang.  Targeting glycolysis for cancer therapy using drug delivery systems. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[14]  N. Tumino,et al.  The tumor microenvironment drives NK cell metabolic dysfunction leading to impaired antitumor activity , 2022, International journal of cancer.

[15]  Ling Ding,et al.  The impact of lipids on the cancer–immunity cycle and strategies for modulating lipid metabolism to improve cancer immunotherapy , 2022, Acta pharmaceutica Sinica. B.

[16]  Zhuxian Zhou,et al.  The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives. , 2022, Advanced drug delivery reviews.

[17]  Yaping Li,et al.  Blocking Cholesterol Metabolism with Tumor‐Penetrable Nanovesicles to Improve Photodynamic Cancer Immunotherapy , 2022, Small methods.

[18]  Ping-Chih Ho,et al.  Metabolic communication in the tumour–immune microenvironment , 2022, Nature Cell Biology.

[19]  Jun Zhang,et al.  Reprogramming dysfunctional dendritic cells by a versatile metabolism nano-intervenor for enhancing cancer combinatorial immunotherapy , 2022, Nano Today.

[20]  Wangxiao He,et al.  Nanomedicines Targeting Metabolism in the Tumor Microenvironment , 2022, Frontiers in Bioengineering and Biotechnology.

[21]  Guangji Wang,et al.  Metabolic intervention liposome for targeting glutamine-addiction of breast cancer. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Tamara J Laskowski,et al.  Natural killer cells in antitumour adoptive cell immunotherapy , 2022, Nature Reviews Cancer.

[23]  Shuang Wang,et al.  Engineered biomimetic nanoparticles achieve targeted delivery and efficient metabolism-based synergistic therapy against glioblastoma , 2022, Nature Communications.

[24]  Xinyang Li,et al.  A Nanounit Strategy Disrupts Energy Metabolism and Alleviates Immunosuppression for Cancer Therapy. , 2022, Nano letters.

[25]  Lei Wang,et al.  Biomimetic Nanoplatform Loading Type I Aggregation-Induced Emission Photosensitizer and Glutamine Blockade to Regulate Nutrient Partitioning for Enhancing Antitumor Immunotherapy. , 2022, ACS nano.

[26]  A. Regev,et al.  Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy , 2022, Cell.

[27]  G. Kucera,et al.  Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression , 2022, Science Translational Medicine.

[28]  Tianfeng Chen,et al.  Designing Lactate Dehydrogenase-Mimicking SnSe Nanosheets To Reprogram Tumor-Associated Macrophages for Potentiation of Photothermal Immunotherapy. , 2022, ACS applied materials & interfaces.

[29]  Xia Li,et al.  Metabolism and polarization regulation of macrophages in the tumor microenvironment. , 2022, Cancer letters.

[30]  Yong Wang,et al.  Nanodrug simultaneously regulates stromal extracellular matrix and glucose metabolism for effective immunotherapy against orthotopic pancreatic cancer , 2022, Nano Today.

[31]  Yongzhuo Huang,et al.  Anti-alcoholism drug disulfiram for targeting glioma energy metabolism using BBB-penetrating delivery of fixed-dose combination , 2022, Nano Today.

[32]  J. Zhang,et al.  Simultaneous glutamine metabolism and PD-L1 inhibition to enhance suppression of triple-negative breast cancer , 2022, Journal of Nanobiotechnology.

[33]  B. Nelson,et al.  Tumour immunotherapy: lessons from predator–prey theory , 2022, Nature Reviews Immunology.

[34]  Jialei Yang,et al.  Advanced nanomedicines for the regulation of cancer metabolism. , 2022, Biomaterials.

[35]  Peisheng Xu,et al.  A Therapeutic Sheep in Metastatic Wolf’s Clothing: Trojan Horse Approach for Cancer Brain Metastases Treatment , 2022, Nano-Micro Letters.

[36]  S. Zelenay,et al.  Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations , 2022, Nature Communications.

[37]  Lingrong Liu,et al.  Biomimetic Nanocarriers Guide Extracellular ATP Homeostasis to Remodel Energy Metabolism for Activating Innate and Adaptive Immunity System , 2022, Advanced science.

[38]  Xiaodong Zhang,et al.  Nanozymes: Versatile Platforms for Cancer Diagnosis and Therapy , 2022, Nano-Micro Letters.

[39]  Xu Liu,et al.  Reactivation of dysfunctional dendritic cells by a stress-relieving nanosystem resets anti-tumor immune landscape , 2022, Nano Today.

[40]  Yannan Yang,et al.  A Sub-6 nm MnFe2O4-dichloroacetic acid nanocomposite modulates tumor metabolism and catabolism for reversing tumor immunosuppressive microenvironment and boosting immunotherapy. , 2022, Biomaterials.

[41]  Yan Yang,et al.  Targeting the Negative Feedback of Adenosine‐A2AR Metabolic Pathway by a Tailored Nanoinhibitor for Photothermal Immunotherapy , 2022, Advanced science.

[42]  Sahil Inamdar,et al.  Drug delivery for metabolism targeted cancer immunotherapy. , 2022, Advanced drug delivery reviews.

[43]  Jia Wei,et al.  Fatty Acid Metabolism and Cancer Immunotherapy , 2022, Current Oncology Reports.

[44]  Hui‐Fen Ma,et al.  Glutamine Metabolism-Regulated Nanoparticles to Enhance Chemoimmunotherapy by Increasing Antigen Presentation Efficiency. , 2022, ACS applied materials & interfaces.

[45]  Qi Zhang,et al.  Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer. , 2022, Seminars in cancer biology.

[46]  Xiaojing Liu,et al.  Dynamic Adjust of Non‐Radiative and Radiative Attenuation of AIE Molecules Reinforces NIR‐II Imaging Mediated Photothermal Therapy and Immunotherapy , 2022, Advanced science.

[47]  Mingwu Shen,et al.  Fibronectin-Coated Metal-Phenolic Networks for Cooperative Tumor Chemo-/Chemodynamic/Immune Therapy via Enhanced Ferroptosis-Mediated Immunogenic Cell Death. , 2022, ACS nano.

[48]  Shiying Li,et al.  Self-Delivery Ternary Bioregulators for Photodynamic Amplified Immunotherapy by Tumor Microenvironment Reprogramming. , 2022, ACS nano.

[49]  Q. Lu,et al.  Light‐Triggered Efficient Sequential Drug Delivery of Biomimetic Nanosystem for Multimodal Chemo‐, Antiangiogenic, and Anti‐MDSC Therapy in Melanoma , 2022, Advanced materials.

[50]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[51]  Kanyi Pu,et al.  Semiconducting Polymer Nano-regulators with Cascading Activation for Photodynamic Cancer Immunotherapy. , 2021, Angewandte Chemie.

[52]  Kanyi Pu,et al.  Smart Nano‐PROTACs Reprogram Tumor Microenvironment for Activatable Photo‐metabolic Cancer Immunotherapy , 2021, Angewandte Chemie.

[53]  C. Dang,et al.  Targeting cancer metabolism in the era of precision oncology , 2021, Nature reviews. Drug discovery.

[54]  D. Hoft,et al.  Tumor microenvironment metabolites directing T cell differentiation and function. , 2021, Trends in immunology.

[55]  Kai Yang,et al.  Coordination Polymer‐Coated CaCO3 Reinforces Radiotherapy by Reprogramming the Immunosuppressive Metabolic Microenvironment , 2021, Advanced materials.

[56]  Xiaoding Xu,et al.  Reduction-responsive RNAi nanoplatform to reprogram tumor lipid metabolism and repolarize macrophage for combination pancreatic cancer therapy. , 2021, Biomaterials.

[57]  Ruibing Wang,et al.  Polyprodrug Nanomedicines: An Emerging Paradigm for Cancer Therapy , 2021, Advanced materials.

[58]  A. Lucas,et al.  A Forgotten Corner in Cancer Immunotherapy: The Role of Lipids , 2021, Frontiers in Oncology.

[59]  Yan Yang,et al.  Nanofactory for metabolic and chemodynamic therapy: pro-tumor lactate trapping and anti-tumor ROS transition , 2021, Journal of Nanobiotechnology.

[60]  S. Vardhana,et al.  Metabolic regulation of the cancer-immunity cycle. , 2021, Trends in immunology.

[61]  Xuesi Chen,et al.  Precise regulation of inflammation and immunosuppressive microenvironment for amplified photothermal/immunotherapy against tumour recurrence and metastasis , 2021 .

[62]  Xiaolin Huang,et al.  Manipulating Intratumoral Fenton Chemistry for Enhanced Chemodynamic and Chemodynamic‐Synergized Multimodal Therapy , 2021, Advanced materials.

[63]  Xiaoling Hu,et al.  Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming. , 2021, Cell metabolism.

[64]  S. Yao,et al.  Mito‐Bomb: Targeting Mitochondria for Cancer Therapy , 2021, Advanced materials.

[65]  Na Li,et al.  GSH-Responsive Nanoprodrug to Inhibit Glycolysis and Alleviate Immunosuppression for Cancer Therapy. , 2021, Nano letters.

[66]  Lihua Luo,et al.  Dual Inhibition of Endoplasmic Reticulum Stress and Oxidation Stress Manipulates the Polarization of Macrophages under Hypoxia to Sensitize Immunotherapy. , 2021, ACS nano.

[67]  Qinjun Chen,et al.  Sequentially Triggered Bacterial Outer Membrane Vesicles for Macrophage Metabolism Modulation and Tumor Metastasis Suppression. , 2021, ACS nano.

[68]  Zhifei Wang,et al.  Reinforcing the Induction of Immunogenic Cell Death Via Artificial Engineered Cascade Bioreactor-Enhanced Chemo-Immunotherapy for Optimizing Cancer Immunotherapy. , 2021, Small.

[69]  Cheng Xu,et al.  Second Near‐Infrared Light‐Activatable Polymeric Nanoantagonist for Photothermal Immunometabolic Cancer Therapy , 2021, Advanced materials.

[70]  Yannan Yang,et al.  Ferroptosis-Strengthened Metabolic and Inflammatory Regulation of Tumor-Associated Macrophages Provokes Potent Tumoricidal Activities. , 2021, Nano letters.

[71]  N. Chandel,et al.  Cancer metabolism: looking forward , 2021, Nature Reviews Cancer.

[72]  T. Gress,et al.  Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer , 2021, Nature Communications.

[73]  R. Herbst,et al.  Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC , 2021, Nature Reviews Clinical Oncology.

[74]  R. Geiger,et al.  Metabolic modulation of tumours with engineered bacteria for immunotherapy , 2021, Nature.

[75]  Q. Lu,et al.  Targeted Micellar Phthalocyanine for Lymph Node Metastasis Homing and Photothermal Therapy in an Orthotopic Colorectal Tumor Model , 2021, Nano-micro letters.

[76]  Y. Xiong,et al.  Advancing targeted protein degradation for cancer therapy , 2021, Nature Reviews Cancer.

[77]  J. Lathia,et al.  Cancer stem cell–immune cell crosstalk in tumour progression , 2021, Nature Reviews Cancer.

[78]  Jun Zhou,et al.  Programmed albumin nanoparticles regulate immunosuppressive pivot to potentiate checkpoint blockade cancer immunotherapy , 2021, Nano Research.

[79]  W. Reith,et al.  Arginine-dependent immune responses , 2021, Cellular and Molecular Life Sciences.

[80]  T. Waldmann,et al.  Immunometabolism at the Nexus of Cancer Therapeutic Efficacy and Resistance , 2021, Frontiers in Immunology.

[81]  J. Swinnen,et al.  Lipid metabolism in cancer: New perspectives and emerging mechanisms. , 2021, Developmental cell.

[82]  Greg M. Delgoffe,et al.  Metabolic barriers to cancer immunotherapy , 2021, Nature Reviews Immunology.

[83]  S. H. van der Burg,et al.  Therapeutic cancer vaccines , 2021, Nature Reviews Cancer.

[84]  Cynthia A. Reinhart-King,et al.  Mechanoresponsive metabolism in cancer cell migration and metastasis. , 2021, Cell metabolism.

[85]  H. Hirte,et al.  Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment. , 2021, Cell metabolism.

[86]  M. Spitzer,et al.  Systemic immunity in cancer , 2021, Nature Reviews Cancer.

[87]  D. Green,et al.  Autophagy in tumour immunity and therapy , 2021, Nature Reviews Cancer.

[88]  L. Wu,et al.  Inspired Epigenetic Modulation Synergy with Adenosine Inhibition Elicits Pyroptosis and Potentiates Cancer Immunotherapy , 2021, Advanced Functional Materials.

[89]  E. Ma,et al.  Immunometabolism in the Tumor Microenvironment , 2021 .

[90]  S. Tenzer,et al.  Inhibition of Arginase 1 Liberates Potent T Cell Immunostimulatory Activity of Human Neutrophil Granulocytes , 2021, Frontiers in Immunology.

[91]  M. Qiao,et al.  Enhanced response to PD-L1 silencing by modulation of TME via balancing glucose metabolism and robust co-delivery of siRNA/Resveratrol with dual-responsive polyplexes. , 2021, Biomaterials.

[92]  Min Su,et al.  The cancer metabolic reprogramming and immune response , 2021, Molecular cancer.

[93]  J. Ji,et al.  Synergistic effect of tumor chemo-immunotherapy induced by leukocyte-hitchhiking thermal-sensitive micelles , 2021, Nature Communications.

[94]  Y. Lou,et al.  Enhanced immune memory through a constant photothermal-metabolism regulation for cancer prevention and treatment. , 2021, Biomaterials.

[95]  G. Bergers,et al.  The metabolism of cancer cells during metastasis , 2021, Nature Reviews Cancer.

[96]  D. Wainwright,et al.  NK cell-based cancer immunotherapy: from basic biology to clinical development , 2021, Journal of Hematology & Oncology.

[97]  Y. Oh,et al.  Nanoparticle-Mediated Lipid Metabolic Reprogramming of T Cells in Tumor Microenvironments for Immunometabolic Therapy , 2021, Nano-micro letters.

[98]  M. Haigis,et al.  Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism , 2021, Nature Metabolism.

[99]  Liang Han,et al.  Evolution of blood–brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies , 2020, Acta pharmaceutica Sinica. B.

[100]  L. Kenner,et al.  The Implications of PDK1–4 on Tumor Energy Metabolism, Aggressiveness and Therapy Resistance , 2020, Frontiers in Oncology.

[101]  Kanyi Pu,et al.  Activatable Polymer Nanoenzymes for Photodynamic Immunometabolic Cancer Therapy , 2020, Advanced materials.

[102]  Jefte M. Drijvers,et al.  Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity , 2020, Cell.

[103]  Shiying Li,et al.  Self-Delivery Photo-Immune Stimulators for Photodynamic Sensitized Tumor Immunotherapy. , 2020, ACS nano.

[104]  Can Zhang,et al.  Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy , 2020, Science Translational Medicine.

[105]  Jiani Chen,et al.  Hypoxia Correlates With Poor Survival and M2 Macrophage Infiltration in Colorectal Cancer , 2020, Frontiers in Oncology.

[106]  Hongyang Wang,et al.  NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion. , 2020, Cell metabolism.

[107]  Dongkai Wang,et al.  Multifunctional Nanoparticles Boost Cancer Immunotherapy Based on Modulating the Immunosuppressive Tumor Microenvironment. , 2020, ACS applied materials & interfaces.

[108]  Rakesh K. Jain,et al.  Physical traits of cancer , 2020, Science.

[109]  K. Cai,et al.  Engineering of Cascade-Responsive Nanoplatform to Inhibit Lactate Efflux for Enhanced Tumor Chemo-Immunotherapy. , 2020, ACS nano.

[110]  Russell G. Jones,et al.  Immunometabolic Interplay in the Tumor Microenvironment. , 2020, Cancer cell.

[111]  Kanyi Pu,et al.  Recent Progress on Activatable Nanomedicines for Immunometabolic Combinational Cancer Therapy , 2020, Small Structures.

[112]  Xiaoyuan Chen,et al.  Recent Advances in Stimuli-Responsive Platforms for Cancer Immunotherapy. , 2020, Accounts of chemical research.

[113]  Ping-Chih Ho,et al.  Lactate modulation of immune responses in inflammatory versus tumour microenvironments , 2020, Nature Reviews Immunology.

[114]  S. Dhar,et al.  Metabolic Modulation of the Tumor Microenvironment Leads to Multiple Checkpoint Inhibition and Immune Cell Infiltration. , 2020, ACS nano.

[115]  G. Hortobagyi,et al.  Cancer Cell Metabolism Bolsters Immunotherapy Resistance by Promoting an Immunosuppressive Tumor Microenvironment , 2020, Frontiers in Oncology.

[116]  Paul D. Smith,et al.  Challenges and Opportunities in Cancer Drug Resistance. , 2020, Chemical reviews.

[117]  Z. Zeng,et al.  Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance , 2020, Cellular and Molecular Life Sciences.

[118]  J. Powell,et al.  Metabolism of immune cells in cancer , 2020, Nature Reviews Cancer.

[119]  B. Kelly,et al.  Amino Assets: How Amino Acids Support Immunity. , 2020, Cell metabolism.

[120]  Howard Y. Chang,et al.  Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen , 2020, Nature Immunology.

[121]  J. Sosman,et al.  Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies , 2020, Frontiers in Immunology.

[122]  Yakun Wan,et al.  Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery. , 2020, Biomaterials.

[123]  L. Buisseret,et al.  The adenosine pathway in immuno-oncology , 2020, Nature Reviews Clinical Oncology.

[124]  J. Rathmell,et al.  Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy. , 2020, Molecular cell.

[125]  P. Sun,et al.  Efficiently restoring the tumoricidal immunity against resistant malignancies via an immune nanomodulator. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[126]  M. Lenardo,et al.  A guide to cancer immunotherapy: from T cell basic science to clinical practice , 2020, Nature Reviews Immunology.

[127]  N. Hay,et al.  Identifying strategies to target the metabolic flexibility of tumours , 2020, Nature Metabolism.

[128]  M. Hung,et al.  ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis. , 2020, Cancer cell.

[129]  Man Li,et al.  Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[130]  R. Deberardinis,et al.  We need to talk about the Warburg effect , 2020, Nature Metabolism.

[131]  A. Longatto-Filho,et al.  Competitive glucose metabolism as a target to boost bladder cancer immunotherapy , 2020, Nature Reviews Urology.

[132]  C. López-Larrea,et al.  Crosstalk Between Hypoxia and ER Stress Response: A Key Regulator of Macrophage Polarization , 2020, Frontiers in Immunology.

[133]  D. Campana,et al.  NK cells for cancer immunotherapy , 2020, Nature Reviews Drug Discovery.

[134]  Xingfa Gao,et al.  Two-dimension tin selenide (SnSe) nanosheets capable of mimicking key dehydrogenases in cellular metabolism. , 2019, Angewandte Chemie.

[135]  J. Manzo-Merino,et al.  Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches , 2019, Front. Oncol..

[136]  Y. Qu,et al.  Catalytically Selective Chemotherapy from Tumor-Metabolic Generated Lactic Acid. , 2019, Small.

[137]  R. Deberardinis,et al.  Mechanisms and Implications of Metabolic Heterogeneity in Cancer. , 2019, Cell metabolism.

[138]  I. Melero,et al.  Dendritic cells in cancer immunology and immunotherapy , 2019, Nature Reviews Immunology.

[139]  L. Galluzzi,et al.  Macrophages and Metabolism in the Tumor Microenvironment. , 2019, Cell metabolism.

[140]  P. Romero,et al.  Navigating metabolic pathways to enhance antitumour immunity and immunotherapy , 2019, Nature Reviews Clinical Oncology.

[141]  David K. Finlay,et al.  Competition for nutrients and its role in controlling immune responses , 2019, Nature Communications.

[142]  E. Pearce,et al.  Metabolic interventions in the immune response to cancer , 2019, Nature Reviews Immunology.

[143]  Qin Xu,et al.  Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin/JQ1. , 2019, Nano letters.

[144]  G. Prendergast,et al.  Immune control by amino acid catabolism during tumorigenesis and therapy , 2019, Nature Reviews Cancer.

[145]  G. E. Fernandez,et al.  Plasminogen Activator Inhibitor-1 Promotes the Recruitment and Polarization of Macrophages in Cancer. , 2018, Cell reports.

[146]  E. Oldfield,et al.  The Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery , 2018, Cell.

[147]  Marie Evangelista,et al.  Pan-Cancer Metabolic Signature Predicts Co-Dependency on Glutaminase and De Novo Glutathione Synthesis Linked to a High-Mesenchymal Cell State. , 2018, Cell metabolism.

[148]  Haiyoung Jung,et al.  Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation , 2018, Front. Immunol..

[149]  Xiaohu Zheng,et al.  Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression. , 2018, Cell metabolism.

[150]  F. He,et al.  Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression , 2018, Nature Communications.

[151]  G. Georgiou,et al.  Reversal of IDO-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme , 2018, Nature Biotechnology.

[152]  R. Davis,et al.  Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy. , 2018, Cell metabolism.

[153]  Sun-Hee Kim,et al.  Impact of l-Arginine Metabolism on Immune Response and Anticancer Immunotherapy , 2018, Front. Oncol..

[154]  Yi Fang,et al.  Tumor-Repopulating Cells Induce PD-1 Expression in CD8+ T Cells by Transferring Kynurenine and AhR Activation. , 2018, Cancer cell.

[155]  A. Benammar Elgaaied,et al.  Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy , 2018, Front. Immunol..

[156]  J. Pouysségur,et al.  The Central Role of Amino Acids in Cancer Redox Homeostasis: Vulnerability Points of the Cancer Redox Code , 2017, Front. Oncol..

[157]  Chenqi Xu,et al.  Cholesterol Metabolism in T Cells , 2017, Front. Immunol..

[158]  M. Smyth,et al.  Targeting immunosuppressive adenosine in cancer , 2017, Nature Reviews Cancer.

[159]  G. Freeman,et al.  Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy. , 2017, Cancer cell.

[160]  Haitao Guan,et al.  Autophagy suppresses isoprenaline‐induced M2 macrophage polarization via the ROS/ERK and mTOR signaling pathway , 2017, Free radical biology & medicine.

[161]  Chih-Hung Chou,et al.  α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming , 2017, Nature Immunology.

[162]  K. Flaherty,et al.  Targeted agents and immunotherapies: optimizing outcomes in melanoma , 2017, Nature Reviews Clinical Oncology.

[163]  D. Sabatini,et al.  mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.

[164]  P. Carmeliet,et al.  Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis. , 2016, Cell metabolism.

[165]  A. Schulze,et al.  The multifaceted roles of fatty acid synthesis in cancer , 2016, Nature Reviews Cancer.

[166]  Philippe Foubert,et al.  PI3Kγ is a molecular switch that controls immune suppression , 2016, Nature.

[167]  M. C. Archer,et al.  The interplay between cell signalling and the mevalonate pathway in cancer , 2016, Nature Reviews Cancer.

[168]  Camille Guillerey,et al.  Targeting natural killer cells in cancer immunotherapy , 2016, Nature Immunology.

[169]  Chi V. Dang,et al.  From Krebs to clinic: glutamine metabolism to cancer therapy , 2016, Nature Reviews Cancer.

[170]  A. Ohta.  A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment , 2016, Front. Immunol..

[171]  Wei Yang,et al.  Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism , 2016, Nature.

[172]  David K. Finlay,et al.  Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells , 2016, The Journal of Immunology.

[173]  P. Gaudreau,et al.  CD73-adenosine: a next-generation target in immuno-oncology. , 2016, Immunotherapy.

[174]  R. Schreiber,et al.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression , 2015, Cell.

[175]  S. Rosenberg,et al.  Adoptive cell transfer as personalized immunotherapy for human cancer , 2015, Science.

[176]  T. Sparwasser,et al.  Fatty acid metabolism in the regulation of T cell function. , 2015, Trends in immunology.

[177]  R. Jain,et al.  Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. , 2014, Cancer cell.

[178]  L. Zitvogel,et al.  Molecular mechanisms of ATP secretion during immunogenic cell death , 2013, Cell Death and Differentiation.

[179]  M. Weller,et al.  An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor , 2011, Nature.

[180]  C. Punt,et al.  Cancer immunotherapy – revisited , 2011, Nature Reviews Drug Discovery.

[181]  D. Sabatini,et al.  Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.

[182]  Gregor Rothe,et al.  Inhibitory effect of tumor cell-derived lactic acid on human T cells. , 2007, Blood.

[183]  Kristian Pietras,et al.  High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.

[184]  T. Waldmann,et al.  Immunotherapy: past, present and future , 2003, Nature Medicine.

[185]  Marino Zerial,et al.  Rab proteins as membrane organizers , 2001, Nature Reviews Molecular Cell Biology.